NEW YORK (GenomeWeb News) — Credit-rating firm Fitch Ratings on Thursday raised its outlook for Beckman Coulter to “stable” from “negative,” largely in response to Beckman’s decision to step away from a bidding war with Inverness Medical Innovations over the firms' intent to acquire Biosite.
 
Fitch had lowered Beckman's credit rating in late March, just after Beckman disclosed its intent to buy the diagnostics company for $85 a share.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.